tiprankstipranks
Inventiva SA (FR:IVA)
:IVA
France Market
IVA
Inventiva
RESEARCH TOOLSreports
Want to see FR:IVA full AI Analyst Report?

Inventiva (IVA) Stock News & Sentiment

21 Followers
Premium
Company Announcements
Inventiva SA Bets Big on Pivotal MASH Trial
1M ago
Lanifibranor’s Emerging Role in the MASH Market: Physician Sentiment and Uptake Potential Support a Buy Rating Despite Cash Constraints
Premium
Ratings
Lanifibranor’s Emerging Role in the MASH Market: Physician Sentiment and Uptake Potential Support a Buy Rating Despite Cash Constraints
1M ago
IVA
Inventiva: Strong Balance Sheet and Late-Stage MASH Candidate Lanifibranor Drive Compelling Buy Rating
Premium
Ratings
Inventiva: Strong Balance Sheet and Late-Stage MASH Candidate Lanifibranor Drive Compelling Buy Rating
3M ago
IVA
Positive Buy Rating for Inventiva Driven by Promising Phase 3 Trial and Strong Financial Position
Premium
Ratings
Positive Buy Rating for Inventiva Driven by Promising Phase 3 Trial and Strong Financial Position
5M ago
IVA
Buy Rating for Inventiva: Lanifibranor’s Potential as a Foundational MASH Therapy
Premium
Ratings
Buy Rating for Inventiva: Lanifibranor’s Potential as a Foundational MASH Therapy
7M ago
IVA
Inventiva’s Strategic Focus and Financial Stability Drive Buy Rating Amid Promising Phase 3 Trial Progress
Premium
Ratings
Inventiva’s Strategic Focus and Financial Stability Drive Buy Rating Amid Promising Phase 3 Trial Progress
7M ago
IVA
Buy Rating for Inventiva: Lanifibranor’s Promising Role in Metabolic Disease Treatment
Premium
Ratings
Buy Rating for Inventiva: Lanifibranor’s Promising Role in Metabolic Disease Treatment
8M ago
IVA
More FR:IVA News >

IVA News on the Web

Three new option listings and one option delisting on April 15th
TipRanks News
Neutral
A Look At Inventiva (ENXTPA:IVA) Valuation After Weaker Full Year 2025 Earnings
Simply Wall St
Neutral
A Look At Inventiva (ENXTPA:IVA) Valuation As NATiV3 Enrollment Completes And Odiparcil Rights Are Sold
Simply Wall St
Bullish
Guggenheim Keeps Their Buy Rating on Inventiva (IVA)
TipRanks News
Bullish
Inventiva (ENXTPA:IVA) Loss Worsening To €175.9m Tests Bullish Efficiency Narratives
Simply Wall St
Neutral
Inventiva price target lowered to $15 from $17 at Stifel
TipRanks News
Bullish
LifeSci Capital Sticks to Their Buy Rating for Inventiva (IVA)
TipRanks News
Bullish
Inventiva management to meet with Piper Sandler
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
FR:IVA
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.25 articles
News Sentiment
This Week50%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FR:IVA’s Media Buzz Sentiment?
1 articles about FR:IVA were published this week. In an average week, 2.25 articles are published.
    What is FR:IVA’s weekly average amount of articles?
    In an average week, 2.25 articles about FR:IVA are published.
      What is FR:IVA’s News Sentiment?
      Currently, no data Available
      General Stocks that are Trending in the News
      JANJanus Living, Inc. Class A
      GMTLGuardian Metal Resources PLC Sponsored ADR
      0IIHKering SA
      OMGOmai Gold Mines
      Showing the stocks with the most bullish news sentiment over the past week